Focal therapy in prostate cancer: international multidisciplinary consensus on trial design.

@article{Bos2014FocalTI,
  title={Focal therapy in prostate cancer: international multidisciplinary consensus on trial design.},
  author={Willemien van den Bos and Berrend G Muller and Hashim Uddin Ahmed and Chris H. Bangma and Eric Barret and S{\'e}bastien M. Crouzet and Scott Eggener and Inderbir S. Gill and Steven Joniau and Gabriella Kov{\'a}cs and Sascha A. Pahernik and Jean J. M. C. H. de la Rosette and Olivier Rouvi{\`e}re and G. Zaat Salomon and John F. Ward and Peter T. Scardino},
  journal={European urology},
  year={2014},
  volume={65 6},
  pages={1078-83}
}
BACKGROUND Focal therapy has been introduced for the treatment of localised prostate cancer (PCa). To provide the necessary data for consistent assessment, all focal therapy trials should be performed according to uniform, systematic pre- and post-treatment evaluation with well-defined end points and strict inclusion and exclusion criteria. OBJECTIVE To… CONTINUE READING